Internal medicine, Endocrinology, Inflammation, Pharmacology and Receptor are his primary areas of study. His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology. His Endocrinology research includes themes of Serotonin, Colitis and Mechanism of action.
The study incorporates disciplines such as Cyclooxygenase and Neuroscience in addition to Inflammation. His studies in Pharmacology integrate themes in fields like Anesthesia, Antagonist and Chemotherapy. The concepts of his Enteric nervous system study are interwoven with issues in Neuroglia, Adrenergic receptor, Neurotransmitter receptor, Neurotransmission and Cell biology.
His main research concerns Internal medicine, Endocrinology, Enteric nervous system, Immunology and Inflammation. Many of his studies on Internal medicine apply to Gastroenterology as well. As a member of one scientific family, he mostly works in the field of Endocrinology, focusing on Cannabinoid receptor and, on occasion, Endocannabinoid system.
His research investigates the connection between Enteric nervous system and topics such as Myenteric plexus that intersect with issues in Neuron. As part of his studies on Inflammation, he often connects relevant areas like Nitric oxide synthase. The various areas that Keith A. Sharkey examines in his Colitis study include Inflammatory bowel disease and Serotonin.
Keith A. Sharkey mainly focuses on Colitis, Internal medicine, Immunology, Endocrinology and Enteric nervous system. His Colitis study combines topics from a wide range of disciplines, such as Inflammation, Serotonin, Inflammatory bowel disease and Pharmacology. As part of his studies on Internal medicine, Keith A. Sharkey frequently links adjacent subjects like Gastroenterology.
His work focuses on many connections between Immunology and other disciplines, such as Gastrointestinal tract, that overlap with his field of interest in Disease, Tumor microenvironment, Carcinogenesis and Cancer research. His work carried out in the field of Endocrinology brings together such families of science as Cannabinoid, Endocannabinoid system and Cannabinoid receptor. Keith A. Sharkey has researched Enteric nervous system in several fields, including Immunohistochemistry, Myenteric plexus, Epithelium, Intestinal permeability and Cell biology.
His primary areas of study are Internal medicine, Immunology, Colitis, Endocrinology and Immune system. His Internal medicine study frequently links to related topics such as Diazepam. His Immunology study integrates concerns from other disciplines, such as Gastrointestinal tract and Disease.
His Colitis research incorporates themes from Kainic acid, Inflammatory bowel disease, Inflammation, Ulcerative colitis and Hyperalgesia. His research investigates the connection between Inflammation and topics such as Intestinal mucosa that intersect with problems in Motility. His Endocrinology research integrates issues from Cannabinoid and Cannabinoid receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors
Marja D. Van Sickle;Marnie Duncan;Philip J. Kingsley;Abdeslam Mouihate.
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome
Matthew D. Coates;Christine R. Mahoney;David R. Linden;Joanna E. Sampson.
Role for protease activity in visceral pain in irritable bowel syndrome.
Nicolas Cenac;Christopher N. Andrews;Marinella Holzhausen;Kevin Chapman.
Journal of Clinical Investigation (2007)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone;Itai Bab;Tamás Bíró;Guy A. Cabral.
Trends in Pharmacological Sciences (2015)
Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.
Brian K. Reuter;Samuel Asfaha;André Buret;Keith A. Sharkey.
Journal of Clinical Investigation (1996)
Recurrent aphthous ulcers today: a review of the growing knowledge
S.S. Natah;S.S. Natah;Y.T. Konttinen;N.S. Enattah;N. Ashammakhi.
International Journal of Oral and Maxillofacial Surgery (2004)
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.
N. Vergnolle;N.W. Bunnett;K.A. Sharkey;V. Brussee.
Nature Medicine (2001)
Cannabinoids and the Gut: New Developments and Emerging Concepts
Angelo A. Izzo;Keith A. Sharkey.
Pharmacology & Therapeutics (2010)
Cyclooxygenase 1 Contributes to Inflammatory Responses in Rats and Mice: Implications for Gastrointestinal Toxicity
John L. Wallace;Adrian Bak;Webb McKnight;Samuel Asfaha.
Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation
Kiarash Riazi;Michael A. Galic;J. Brent Kuzmiski;Winnie Ho.
Proceedings of the National Academy of Sciences of the United States of America (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: